One New IPO Scheduled for July 7th Week

Francis Gaskins |

After Memorial Day June turned into a very active IPO month – with 29 IPOs. Chances are very good that July through August 12 or so will also be very active.

Complete IPO calendar at IPOpremium.com



NEW:  Based in Somerset, NJ,Medical Transcription Billing (MTBC) scheduled a $30 million IPO on the Nasdaq with a market capitalization of $96 million at a price range midpoint of $10 for Thursday, July 10, 2014.

HOLDOVERS:
(1) Based in Emeryville, CA, KineMed (KNMD) scheduled a $31 million IPO on the Nasdaq with a market capitalization of $114 million at a price range midpoint of $7 for the week of July 7th, originally scheduled for Wednesday June 24, 2014.

(2) Based in New York, NY, Microlin Bio (MCLB) scheduled a $30 million IPO on the Nasdaq with a market capitalization of $75 million at a price range midpoint of $11 for the week of July7th, originally scheduled for Wednesday, June 18, 2014.

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of equities.com. Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to: http://www.equities.com/disclaimer

Companies

Symbol Name Price Change % Volume
MTBC Medical Transcription Billing Corp. 1.28 0.05 4.07 377,097 Trade
HEO:CA H2O Innovation Inc. 1.37 0.02 1.48 20,600

Comments

Emerging Growth

THC Therapeutics Inc

THC Therapeutics Inc is a health and healing company in the cannabis industry. The Company is engaged in developing dHydronator which is used to reduce moisture and effectively dry out…

Private Markets

iPRO Network, LLC

We provide the platform, tools, and resources to empower individuals and professionals to market desirable goods and services to the public, taking the place of traditional methods of commerce.

Quants Inc

Quants, Inc, a California Corporation, develops, markets and operates financial technology platforms and alternative investment products offering sophisticated risk management since 2010. The Company has primarily sharpened its focus with…